Author

Kentaro Sakamaki

Juntendo University - Cited by 4,461 - Biostatistics - Clinical Trials - Epidemiology

Biography

Kentaro Sakamaki currently is working in Department of Biostatistics and Epidemiology, Yokohama City University Graduate School of Medicine, Urafune, Minami-ku, Yokohama, Kanagawa, Japan. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his/her valuable service towards the scientific community with his extensive research work.
Title
Cited by
Year
Mass screening of asymptomatic persons for severe acute respiratory syndrome coronavirus 2 using Saliva
I Yokota, PY Shane, K Okada, Y Unoki, Y Yang, T Inao, K Sakamaki, ...Clinical Infectious Diseases 73 (3), e559-e565, 2021202
172
2021
The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis
K Sugimoto, F Moriyasu, H Oshiro, H Takeuchi, M Abe, Y Yoshimasu, ...Radiology 296 (3), 532-540, 2020202
120
2020
Drain Placement After Uncomplicated Hepatic Resection Increases Severe Postoperative Complication Rate: A Japanese Multi-institutional Randomized Controlled Trial (ND-trial)
J Arita, K Sakamaki, A Saiura, M Konishi, Y Sakamoto, M Hashimoto, ...Annals of surgery 273 (2), 224-231, 2021202
25
2021
Impact of the micropapillary component on the timing of recurrence in patients with resected lung adenocarcinoma
K Watanabe, K Sakamaki, H Ito, T Yokose, K Yamada, H Nakayama, ...European Journal of Cardio-Thoracic Surgery 58 (5), 1010-1018, 2020202
24
2020
Multiparametric US for Identifying Patients with High-Risk NASH: A Derivation and Validation Study
K Sugimoto, DH Lee, JY Lee, SJ Yu, F Moriyasu, K Sakamaki, H Oshiro, ...Radiology 301 (3), 625-634, 2021202
17
2021
Grading Severity and Bother Using the International Prostate Symptom Score and International Consultation on Incontinence Questionnaire Male Lower Urinary Tract Symptoms Score …
H Ito, G Young, A Lewis, P Blair, N Cotterill, J Lane, K Sakamaki, M Drake, ...The Journal of Urology 204 (5), 1003-1011, 2020202
13
2020
Randomized phase II study of chemoradiotherapy with cisplatin+ S-1 versus cisplatin+ pemetrexed for locally advanced non-squamous non-small cell lung cancer: SPECTRA study
S Niho, T Yoshida, T Akimoto, K Sakamaki, A Ono, T Seto, M Nishio, ...Lung Cancer 141, 64-71, 2020202
10
2020
Validation of tissue factor pathway inhibitor 2 as a specific biomarker for preoperative prediction of clear cell carcinoma of the ovary
E Miyagi, N Arakawa, K Sakamaki, NR Yokota, T Yamanaka, Y Yamada, ...International Journal of Clinical Oncology 26 (7), 1336-1344, 2021202
10
2021
Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study
T Ishikawa, K Sakamaki, K Narui, H Nishimura, T Sangai, K Tamaki, ...The Breast 56, 70-77, 2021202
8
2021
Magnetically Guided Localization Using a Guiding-Marker System® and a Handheld Magnetic Probe for Nonpalpable Breast Lesions: A Multicenter Feasibility Study in Japan
T Kurita, K Taruno, S Nakamura, H Takei, K Enokido, T Kuwayama, ...Cancers 13 (12), 2923, 2021202
8
2021
Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as …
T Hayashi, T Yoshikawa, K Sakamaki, K Nishikawa, K Fujitani, K Tanabe, ...Annals of Gastroenterological Surgery 4 (5), 540-54, 2020202
8
2020
Noninvasive Diagnosis of Hepatocellular Carcinoma on Sonazoid-Enhanced US: Value of the Kupffer Phase
H Takahashi, K Sugimoto, N Kamiyama, K Sakamaki, T Kakegawa, ...Diagnostics 12 (1), 141, 2022202
7
2022
Survival analysis of a prospective multicenter observational study on surgical palliation among patients receiving treatment for malignant gastric outlet obstruction caused by …
M Terashima, K Fujitani, M Ando, K Sakamaki, R Kawabata, Y Ito, ...Gastric Cancer 24, 224-231, 2021202
7
2021
Definitions and elements of endpoints in phase III randomized trials for the treatment of COVID-19: a cross-sectional analysis of trials registered in ClinicalTrials. gov
K Sakamaki, Y Uemura, Y ShimizuTrials 22 (1), 1-9, 2021202
5
2021
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study
Y Ito, K Fujitani, K Sakamaki, M Ando, R Kawabata, Y Tanizawa, ...Gastric Cancer 2, 1131-1139, 2021202
4
2021
The efficacy of sequential second-line endocrine therapies (ETs) in postmenopausal estrogen receptor-positive and HER2-negative metastatic breast cancer patients with lower …
T Iwamoto, T Fujisawa, T Shien, K Araki, K Sakamaki, T Sangai, Y Kikawa, ...Breast Cancer 27, 973-981, 2020202
4
2020
Experience of distance education for project-based learning in data science
K Sakamaki, M Taguri, H Nishiuchi, Y Akimoto, K KoizumiJapanese Journal of Statistics and Data Science 5 (2), 757-767, 2022202
4
2022
Multicentre randomised phase II study of the perioperative administration of flurbiprofen axetil in patients with non-small cell lung cancer: study protocol of the FLAX Study
K Sakamaki, K Watanabe, T Woo, M MasudaBMJ open 10 (11), e00969, 2020202
4
2020
Effects of perioperative eicosapentaenoic acid‑enriched oral nutritional supplement on the long‑term oncological outcomes after total gastrectomy for gastric cancer
T Aoyama, T Yoshikawa, S Ida, H Cho, K Sakamaki, Y Ito, K Fujitani, ...Oncology Letters 23 (5), 1-6, 2022202
4
2022
Comparison of modified CEUS LI‐RADS with sonazoid and CT/MRI LI‐RADS for diagnosis of hepatocellular carcinoma
K Sugimoto, K Saito, N Shirota, N Kamiyama, K Sakamaki, H Takahashi, ...Hepatology Research 52 (8), 70-78, 2022202
3
2022

Referred From: https://scholar.google.com/citations?hl=en&user=EFa41jwAAAAJ

Cited by
Citations 4461
h-index 33
i10-index 90
Recommended Journals
Open Access Journals